Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1

Blood

Volumn 124, Issue 17, 2014, Pages 2647-2656

  Won, Haejung ^a   Nandakumar, Vijayalakshmi ^a   Yates, Peter ^a   Sanchez, Suzi ^a   Jones, Lindsey ^a   Huang, Xue F ^a   Chen, Si Yi ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE H2A DEUBIQUITINASE MYSM1; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; CD135 ANTIGEN; COLONY STIMULATING FACTOR RECEPTOR; FLT3 PROTEIN, MOUSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HISTONE; MYSM1 PROTEIN, MOUSE; ONCOPROTEIN; PROTEIN BINDING; PROTEINASE; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENETIC REGULATION; GRANULOCYTE; HISTONE MODIFICATION; MACROPHAGE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PROMOTER REGION; ANIMAL; CELL CULTURE; DRUG EFFECTS; FLOW CYTOMETRY; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENDOPEPTIDASES; EPIGENESIS, GENETIC; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEK293 CELLS; HISTONES; HUMANS; MICE, KNOCKOUT; MYELOID PROGENITOR CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 84908245248     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-534313     Document Type: Article

References (41)

1. Schmid MA, Kingston D, Boddupalli S, Manz MG. Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev. 2010;234(1):32-44.
2. Ebner S, Ratzinger G, Krösbacher B, et al. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol. 2001;166(1):633-641.
3. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992;176(6):1693-1702.
4. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
5. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol. 2007;179(11):7577-7584.
6. Vremec D, Lieschke GJ, Dunn AR, Robb L, Metcalf D, Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol. 1997;27(1):40-44.
7. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000;96(9):3029-3039.
8. Gilliet M, Boonstra A, Paturel C, et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 2002;195(7):953-958.
9. McKenna HJ. Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells. Curr Opin Hematol. 2001;8(3):149-154.
10. Waskow C, Liu K, Darrasse-Jèze G, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9(6):676-683.
11. Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood. 2009;114(4):835-843.
12. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt31 lymphoid and myeloid-committed progenitors to Flt31 dendritic cells in vivo. J Exp Med. 2003;198(2):305-313.
13. D'Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med. 2003;198(2):293-303.
14. Zhu P, Zhou W, Wang J, et al. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol Cell. 2007;27(4):609-621.
15. Jiang XX, Nguyen Q, Chou Y, et al. Control of B cell development by the histone H2A deubiquitinase MYSM1. Immunity. 2011;35(6):883-896.
16. Wang T, Nandakumar V, Jiang XX, et al. The control of hematopoietic stem cell maintenance, self- renewal, and differentiation by Mysm1-mediated epigenetic regulation. Blood. 2013;122(16):2812-2822.
17. Nijnik A, Clare S, Hale C, et al; Sanger Institute Microarray Facility; Sanger Mouse Genetics Project. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation. Blood. 2012;119(6):1370-1379.
18. Song XT, Evel-Kabler K, Shen L, Rollins L, Huang XF, Chen SY. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med. 2008;14(3):258-265.
19. Sharabi AB, Aldrich M, Sosic D, et al. Twist-2 controls myeloid lineage development and function. PLoS Biol. 2008;6(12):e316.
20. Zhou W, Zhu P, Wang J, et al. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol Cell. 2008;29(1):69-80.
21. Shen L, Evel-Kabler K, Strube R, Chen SY. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat Biotechnol. 2004;22(12):1546-1553.
22. Carotta S, Dakic A, D'Amico A, et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity. 2010;32(5):628-641.
23. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19(1):59-70.
24. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev. 2010;234(1):45-54.
25. Liu K, Victora GD, Schwickert TA, et al. In vivo analysis of dendritic cell development and homeostasis. Science. 2009;324(5925):392-397.
26. Satpathy AT, Murphy KM, Kc W. Transcription factor networks in dendritic cell development. Semin Immunol. 2011;23(5):388-397.
27. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet. 2009;43:559-599.
28. Gelato KA, Fischle W. Role of histone modifications in defining chromatin structure and function. Biol Chem. 2008;389(4):353-363.
29. Atanassov BS, Koutelou E, Dent SY. The role of deubiquitinating enzymes in chromatin regulation. FEBS Lett. 2011;585(13):2016-2023.
30. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
31. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med. 2005;201(2):221-231.
32. Back J, Allman D, Chan S, Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp Hematol. 2005;33(4):395-402.
33. Guerriero A, Langmuir PB, Spain LM, Scott EWPU. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood. 2000;95(3):879-885.
34. Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol. 2000;164(4):1855-1861.
35. Kastner P, Chan S. PU.1: a crucial and versatile player in hematopoiesis and leukemia. Int J Biochem Cell Biol. 2008;40(1):22-27.
36. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DGPU. PU.1 (Spi-21) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol. 1995;15(10):5830-5845.
37. Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol. 1994;14(1):373-381.
38. Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature. 2008;453(7193):306-313.
39. Mende I, Karsunky H, Weissman IL, Engleman EG, Merad M. Flk21 myeloid progenitors are the main source of Langerhans cells. Blood. 2006;107(4):1383-1390.
40. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750-761.
41. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SLPU. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201(9):1487-1502.